HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shunji Takeuchi Selected Research

Pharmaceutical Preparations

8/2003The effects of V2 antagonist (OPC-31260) on endolymphatic hydrops.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shunji Takeuchi Research Topics

Disease

3Endolymphatic Hydrops
01/2004 - 07/2002
2Meniere Disease (Menieres Disease)
01/2004 - 08/2003
1Stomach Neoplasms (Stomach Cancer)
01/2016
1Thyroid Neoplasms (Thyroid Cancer)
06/2006
1Lymphatic Metastasis
06/2006
1Ganglion Cysts (Ganglion)
12/2004

Drug/Important Bio-Agent (IBA)

2Vasopressins (Vasopressin)IBA
08/2003 - 07/2002
1Immunoglobulin G (IgG)IBA
01/2016
1Pepsinogen A (Pepsinogen)IBA
01/2016
1Histamine Receptors (Histamine Receptor)IBA
12/2004
1AntibodiesIBA
12/2004
1Histamine (Histamine Dihydrochloride)FDA Link
12/2004
1neurofilament protein HIBA
12/2004
1Histamine H3 Receptors (Histamine H3 Receptor)IBA
12/2004
1Osmotic DiureticsIBA
01/2004
1IsosorbideFDA Link
01/2004
1Aquaporin 2IBA
08/2003
1Pharmaceutical PreparationsIBA
08/2003
1mozavaptanIBA
08/2003
1Messenger RNA (mRNA)IBA
08/2003

Therapy/Procedure

1Myocutaneous Flap
06/2006